NGGT006
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NGGT006, covering 2024-12-09 to 2024-12-09. Get the full timeline:
Most recent: Clinical Trial Update: NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia [EARLY_Phase 1]